Results
10463
Most Popular Stocks on the market
10,463 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AAPL | US$217.96 | -2.8% | 11.3% | US$3.3t | US$223.05 | PE33.3x | E6.8% | 0.5% | Tech | ||
MSFT | US$425.27 | -2.7% | 25.7% | US$3.2t | US$497.01 | PE36.7x | E12.6% | 0.7% | Software | ||
NVDA | US$113.06 | -4.1% | 141.8% | US$2.8t | US$139.32 | PE65.2x | E23.3% | 0.04% | Semiconductors | ||
GOOGL | US$167.00 | -6.0% | 26.0% | US$2.1t | US$203.84 | PE23.5x | E12.1% | 0.5% | Media | ||
AMZN | US$182.50 | -0.3% | 38.0% | US$1.9t | US$221.95 | PE50.4x | E21.3% | n/a | Retail | ||
META | US$465.70 | -2.3% | 43.1% | US$1.2t | US$532.71 | PE25.8x | E12.2% | 0.4% | Media | ||
BRK.A | US$657,179.99 | 0.8% | 23.3% | US$943.6b | US$679,205.00 | PE12.9x | E-15.4% | n/a | Diversified Financials | ||
LLY | US$804.62 | -6.2% | 75.5% | US$724.5b | US$917.94 | PE118x | E27.4% | 0.6% | Pharmaceuticals & Biotech | ||
AVGO | US$151.63 | -3.6% | 68.5% | US$705.8b | US$192.97 | PE69x | E28.3% | 1.4% | Semiconductors | ||
TSLA | US$219.80 | -8.1% | -17.5% | US$702.2b | US$203.61 | PE56.7x | E17.0% | n/a | Automobiles | ||
JPM | US$212.24 | 1.2% | 35.3% | US$603.8b | US$219.45 | PB1.9x | E-3.7% | 2.2% | Banks | ||
WMT | US$69.78 | -1.4% | 30.9% | US$561.3b | US$73.04 | PE29.6x | E7.0% | 1.2% | Consumer Retailing | ||
UNH | US$569.72 | 0.8% | 13.3% | US$524.4b | US$615.13 | PE37.2x | E23.4% | 1.5% | Healthcare | ||
V | US$259.46 | -2.3% | 10.1% | US$493.6b | US$303.46 | PE26.2x | E9.6% | 0.8% | Diversified Financials | ||
XOM | US$117.33 | 1.1% | 12.6% | US$462.6b | US$132.96 | PE14.1x | E5.9% | 3.2% | Energy | ||
MA | US$438.18 | -1.2% | 11.5% | US$407.3b | US$512.74 | PE34.4x | E11.6% | 0.6% | Diversified Financials | ||
PG | US$169.11 | 0.7% | 8.1% | US$399.1b | US$174.68 | PE26.9x | E6.4% | 2.4% | Household | ||
JNJ | US$160.64 | 3.8% | -7.9% | US$386.7b | US$170.67 | PE23.6x | E6.9% | 3.1% | Pharmaceuticals & Biotech | ||
ORCL | US$139.01 | 0.3% | 19.8% | US$383.1b | US$148.92 | PE36.6x | E15.9% | 1.2% | Software | ||
COST | US$817.60 | -2.4% | 45.1% | US$362.5b | US$881.99 | PE50.5x | E7.4% | 0.6% | Consumer Retailing | ||
HD | US$359.51 | -1.1% | 8.5% | US$356.5b | US$383.14 | PE24x | E5.3% | 2.5% | Retail | ||
ABBV | US$185.16 | 7.5% | 22.7% | US$327.0b | US$192.34 | PE61.7x | E26.3% | 3.3% | Pharmaceuticals & Biotech | ||
BAC | US$41.67 | -2.9% | 30.6% | US$324.0b | US$44.82 | PB1.2x | E8.0% | 2.3% | Banks | ||
MRK | US$125.26 | -0.4% | 17.8% | US$317.3b | US$142.98 | PE137.6x | E23.7% | 2.5% | Pharmaceuticals & Biotech |